(AsthmaHaler Mist)
4,086 results
  • MIST versus INSURE: Superior outcomes in surfactant administration for preterm neonates with RDS. [Journal Article]
    Respir Med. 2026 May 09; 258:108887. [Online ahead of print]Boskabadi H, Afzaljavan F, Zakerihamidi MRM
  • CONCLUSIONS: MIST is a safe and effective alternative to INSURE for surfactant administration in preterm infants with RDS. It is associated with improved short-term outcomes, including shorter mechanical ventilation duration and lower incidences of ROP and sepsis. These findings support MIST as a preferable approach in clinical practice.
  • MIST: A Benchmark and Baseline for Multi-Frame Infrared Small Target Detection in Complex Motion. [Journal Article]
    IEEE Trans Image Process. 2026; 35:5196-5211.Gao R, Zhang M, … Zeng DIT
  • Motion cues play a vital role in multi-frame infrared small target detection (MISTD). However, most targets in existing datasets exhibit regular and slow motion, which cannot reflect the complex and diverse motion patterns in real-world scenarios. This biased data distribution makes recent data-driven methods highly rely on simplified motion assumptions that tend to fail in irregular or fast moti…
  • Electrically Tunable Tunneling and Spectral Response in WSe2/h-BN/CdSe/Graphene Heterostructure. [Journal Article]
    Small. 2026 May 06; :e73645. [Online ahead of print]Lee SH, Teku JA, … Lee JSS
  • Mixed-dimensional heterostructures consisting of zero- and two-dimensional materials offer a promising platform for optoelectronic devices, as the versatility of material combination allows tunable optical properties. Bias-induced approaches provide an additional means to tune the optical properties beyond the intrinsic band alignment of van der Waals junctions. Here, bias-induced tunneling chara…
  • Comparative analysis of real-world acute prescription migraine therapy outcomes: Insights from the HeAD-US study. [Journal Article]
    Headache. 2026 May 04. [Online ahead of print]Teichrow D, Khorsand B, … Ezzati AH
  • CONCLUSIONS: In this large, real-world cohort, triptans and gepants did not significantly differ for 2hPF, but gepants demonstrated a significant advantage for 24hPR. Clinical features such as symptom severity, headache frequency, disability, and comorbid treatment burden were important predictors of treatment response. These findings support the need for larger, head-to-head clinical trials definitively comparing these medication classes for migraine management and may inform personalized selection of acute migraine therapies in clinical practice.